DA Davidson lowered shares of Global Medical REIT Inc (NASDAQ:GMRE) from a buy rating to a neutral rating in a research note released on Tuesday morning, MarketBeat reports. The firm currently has $10.00 target price on the stock, down from their previous target price of $11.00.

Other equities research analysts also recently issued reports about the stock. Zacks Investment Research raised shares of Global Medical REIT from a hold rating to a buy rating and set a $10.00 price target for the company in a report on Wednesday, July 12th. TheStreet raised shares of Global Medical REIT from a d rating to a c- rating in a report on Monday, July 10th. Finally, FBR & Co reissued an outperform rating and issued a $10.00 price target on shares of Global Medical REIT in a report on Tuesday, July 11th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Global Medical REIT presently has an average rating of Buy and an average price target of $10.00.

Global Medical REIT (NASDAQ GMRE) opened at 8.79 on Tuesday. The company’s 50 day moving average is $9.04 and its 200 day moving average is $9.05. Global Medical REIT has a 52-week low of $6.73 and a 52-week high of $10.95.

Global Medical REIT (NASDAQ:GMRE) last issued its quarterly earnings results on Thursday, August 10th. The company reported ($0.04) earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.13 by $0.17. Global Medical REIT had a negative net margin of 8.39% and a negative return on equity of 1.53%. The business had revenue of $7.42 million during the quarter, compared to analyst estimates of $6.16 million. On average, equities research analysts forecast that Global Medical REIT will post ($0.11) earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This news story was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/26/global-medical-reit-inc-gmre-downgraded-by-da-davidson.html.

In other news, Chairman Jeffrey Busch acquired 11,100 shares of Global Medical REIT stock in a transaction on Friday, June 30th. The stock was bought at an average cost of $9.00 per share, with a total value of $99,900.00. Following the completion of the purchase, the chairman now owns 20,110 shares of the company’s stock, valued at $180,990. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website.

Hedge funds have recently bought and sold shares of the stock. Menta Capital LLC purchased a new stake in Global Medical REIT during the first quarter worth approximately $164,000. BB&T Securities LLC raised its stake in Global Medical REIT by 260.7% in the first quarter. BB&T Securities LLC now owns 53,739 shares of the company’s stock worth $487,000 after buying an additional 38,839 shares in the last quarter. Neuberger Berman Group LLC purchased a new stake in Global Medical REIT during the first quarter worth approximately $601,000. Rational Advisors LLC purchased a new stake in Global Medical REIT during the first quarter worth approximately $2,425,000. Finally, Parametric Portfolio Associates LLC raised its stake in Global Medical REIT by 24.0% in the first quarter. Parametric Portfolio Associates LLC now owns 26,529 shares of the company’s stock worth $241,000 after buying an additional 5,129 shares in the last quarter.

Global Medical REIT Company Profile

Global Medical REIT Inc focuses on operating as a real estate investment trust. The Company is engaged primarily in the acquisition and leasing of licensed purpose-built healthcare facilities in certain markets with various clinical operators. The Company seeks to invest in these purpose-built, specialized facilities, such as surgery centers, specialty hospitals and outpatient treatment centers.

Analyst Recommendations for Global Medical REIT (NASDAQ:GMRE)

Receive News & Stock Ratings for Global Medical REIT Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc and related stocks with our FREE daily email newsletter.